PROVIDER PROFILE · NPI 1801907399

Mythe LaramieM.D.

Internal MedicineFresno, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,455

Unique beneficiaries

—

Total services

3,543

Distinct HCPCS

Medicare payment

$235K

Peer benchmark

Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).

PRESCRIBING · PART D · 2024

Total Rx claims

6,415

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

115

Brand share

25.4%

Top prescribed drugs

Rosuvastatin Calcium517 claims

Ezetimibe503 claims

Atorvastatin Calcium484 claims

Metoprolol Succinate203 claims

Amlodipine Besylate192 claims

QUALITY · MIPS · 2024

Final MIPS score

87.2

Quality

98.1

Cost

59.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.51%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

114

By payment type

Food and Beverage$3K

REFERRAL NETWORK

Where Mythe Laramie's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	117	367
SAINT AGNES MEDICAL CENTER	82	390
WALTON, VICKIE	18	52
FRESNO COMMUNITY HOSPITAL AND MEDICAL CENTER	15	41
Jeannine Laramie Family Practice · Fresno, CA	14	37
Judy Champaign Diagnostic Radiology · Fresno, CA	11	20

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history